Capsule Summary Slidesets

Share

Program Content

Activities

  • AVANOVA2: Niraparib + Bev in OvC
    Phase II AVANOVA2: Niraparib + Bevacizumab vs Niraparib Alone in Platinum-Sensitive Recurrent Ovarian Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 07, 2019

    Expires: June 05, 2020

  • SOLO3: Olaparib in PSOC
    SOLO3: Phase III Trial of Olaparib vs Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and Germline BRCA Mutation
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 11, 2019

    Expires: June 09, 2020

Provided by

ProCE Banner

Supporters

Amgen, Inc.

Astellas Seattle Genetics

Bayer Healthcare Pharma

Blueprint Medicines

Celgene

Novartis Pharmaceuticals Corporation

Puma Biotechnology, Inc.

Taiho Oncology Inc

Tesaro